Skip to content
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article Medicines Used in Mental Health – England – 2015/16 to 2021/22

Medicines Used in Mental Health – England – 2015/16 to 2021/22

  • Post author:Olly PP
  • Post published:July 7, 2022
  • Post category:Industry News

Continue ReadingMedicines Used in Mental Health – England – 2015/16 to 2021/22
Read more about the article Can ‘magic mushrooms’ and MDMA cure depression?

Can ‘magic mushrooms’ and MDMA cure depression?

  • Post author:Olly PP
  • Post published:June 22, 2022
  • Post category:Industry News

Continue ReadingCan ‘magic mushrooms’ and MDMA cure depression?
Read more about the article Psychedelic drugs: A market poised for takeoff

Psychedelic drugs: A market poised for takeoff

  • Post author:Olly PP
  • Post published:June 21, 2022
  • Post category:Industry News

Continue ReadingPsychedelic drugs: A market poised for takeoff
Read more about the article How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more

How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more

  • Post author:Olly PP
  • Post published:June 11, 2022
  • Post category:Industry News

Continue ReadingHow psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more
Read more about the article Tripping over the potential of psychedelics for autism

Tripping over the potential of psychedelics for autism

  • Post author:Olly PP
  • Post published:May 31, 2022
  • Post category:Industry News

Continue ReadingTripping over the potential of psychedelics for autism
Read more about the article Unraveling the Mysteries of Mental Illness With Psilocybin

Unraveling the Mysteries of Mental Illness With Psilocybin

  • Post author:Olly PP
  • Post published:May 27, 2022
  • Post category:Industry News

Continue ReadingUnraveling the Mysteries of Mental Illness With Psilocybin
Read more about the article Combining Antidepressants and Psilocybin: A Look at the Research

Combining Antidepressants and Psilocybin: A Look at the Research

  • Post author:Olly PP
  • Post published:May 27, 2022
  • Post category:Industry News

Continue ReadingCombining Antidepressants and Psilocybin: A Look at the Research
Read more about the article Psychedelics: How They Act on the Brain to Relieve Depression

Psychedelics: How They Act on the Brain to Relieve Depression

  • Post author:Olly PP
  • Post published:May 19, 2022
  • Post category:Industry News

Continue ReadingPsychedelics: How They Act on the Brain to Relieve Depression
Read more about the article First patient in Quebec gets approval from Health Canada for magic mushroom therapy

First patient in Quebec gets approval from Health Canada for magic mushroom therapy

  • Post author:Olly PP
  • Post published:May 17, 2022
  • Post category:Industry News

Continue ReadingFirst patient in Quebec gets approval from Health Canada for magic mushroom therapy
Read more about the article We cannot meet the mental health needs of cancer patients without breaking down silos

We cannot meet the mental health needs of cancer patients without breaking down silos

  • Post author:Olly PP
  • Post published:April 29, 2022
  • Post category:Industry News

Continue ReadingWe cannot meet the mental health needs of cancer patients without breaking down silos
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement
  • Letter of Intent (LOI) for First-In-Human studies with iNGENū CRO
  • Albert Labs Provides Corporate Update
  • Psychedelic Therapy isn’t Fringe Anymore

Recent Comments

    Innovative mental health medicines for patients with unmet needs

    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy
    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy

    © 2022 Albert Labs. All Rights Reserved

    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    Twitter Linkedin Youtube Envelope
    CSE:ABRT
    FSE: VB50
    CSE:ABRT
    FSE: VB50

    About Albert Labs

    We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

    If you would like support or more information around making an investment, please contact investing@albertlabs.com

    Twitter Linkedin Youtube Envelope

    Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

    • This field is for validation purposes and should be left unchanged.

    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    Latest Press Release

    Expansion of Drug Discovery and a Promising Pipeline

    Read more
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    Latest Press Release

    Expansion of Drug Discovery and a Promising Pipeline

    Read more

    By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.